AustarPharma

AustarPharma is a rapidly growing technology based pharmaceutical company located in Edison, NJ. We are engaged in the development, manufacturing, and sales and marketing of generic and other pharmaceutical products developed internally or by our worldwide strategic co-development partners. AustarPharma also continues to offer our clients integrated contract services that provide turn-key solutions ranging from early development to cGMP manufacturing and product sales. AustarPharma was founded as a research and development company, specializing in drug delivery technologies. That strength and commitment has been very strong and has become even stronger today. We welcome the opportunity to help our partners and clients to define, plan and execute their product development strategies and projects. Our cGMP development, manufacturing and testing facility was acquired from Abbott Laboratories in 2009. It has been inspected by the FDA and EU Health Authorities and it is equipped to handle controlled substances (CII-V). AustarPharma has partnered with more than 10 US biotech and pharmaceutical companies including some of the top 10 companies as well as more than 15 overseas major pharmaceutical companies to co-develop strategic and high sales potential pharmaceutical products. Our pipeline is now rich with more than 50 ANDA drug products, among them 4 products approved, around 20 products pending approval, and around 30 funded toward submission to FDA. Our approved products have been sold in the US market since 2011. We welcome you to contact us to discuss potential product development and or sales and marketing partnership opportunities.